T. Rowe Price Associates’s Leonardo DRS DRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108M Sell
2,542,316
-833,985
-25% -$37.1M 0.01% 678
2026
Q1
$150M Buy
3,376,301
+1,275,319
+61% +$53.8M 0.02% 528
2025
Q4
$71.6M Sell
2,100,982
-470,807
-18% -$17.4M 0.01% 707
2025
Q3
$117M Buy
2,571,789
+2,124,482
+475% +$92.6M 0.01% 586
2025
Q2
$20.8M Sell
447,307
-6,253
-1% -$251K ﹤0.01% 947
2025
Q1
$14.9M Sell
453,560
-382,733
-46% -$12.6M ﹤0.01% 1024
2024
Q4
$27M Sell
836,293
-1,122,829
-57% -$36.5M ﹤0.01% 921
2024
Q3
$55.3M Sell
1,959,122
-404,526
-17% -$11.1M 0.01% 730
2024
Q2
$60.3M Buy
2,363,648
+183,301
+8% +$4.19M 0.01% 662
2024
Q1
$48.2M Buy
2,180,347
+290,188
+15% +$6.03M 0.01% 735
2023
Q4
$37.9M Buy
1,890,159
+299,275
+19% +$5.65M 0.01% 779
2023
Q3
$26.6M Buy
1,590,884
+458,171
+40% +$7.73M ﹤0.01% 852
2023
Q2
$19.6M Buy
+1,132,713
New +$17.5M ﹤0.01% 942

Other funds holding DRS

T. Rowe Price Associates's DRS Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Leonardo DRS (DRS) stake by 25% in Q2 2026, selling an estimated $37.1M and leaving 2,542,316 shares worth $108M. The position accounts for 0.01% of the portfolio, ranked #678.

T. Rowe Price Associates first reported a position in DRS in Q2 2023 and has held it in 13 quarters since. The position peaked at $150M in Q1 2026. 379 funds tracked by Wall St. Rank hold DRS as of Q2 2026.

  • T. Rowe Price Associates held 2,542,316 shares of Leonardo DRS worth $108M as of Q2 2026.
  • T. Rowe Price Associates sold 833,985 Leonardo DRS shares in Q2 2026, an estimated $37.1M.
  • Leonardo DRS made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #678 holding.
  • T. Rowe Price Associates first reported a position in Leonardo DRS in Q2 2023 and has held it in 13 quarters since.
  • T. Rowe Price Associates's Leonardo DRS position peaked at $150M in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Leonardo DRS as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.